Literature DB >> 31414606

Therapeutic efficacy of Phyllanthus emblica-coated iron oxide nanoparticles in A549 lung cancer cell line.

Shivani Thoidingjam1, Ashu Bhan Tiku1.   

Abstract

Aim: Present work was undertaken to fabricate iron oxide nanoparticles (IONPs) using a green approach for increased therapeutic efficacy. Materials & methods: Two types of IONPs were synthesized, one without any coating (IONPUC) and other coated with Phyllanthus emblica (Amla) fruit extract (IONPA). Both the IONPs were characterized using different techniques and therapeutic efficacy was evaluated in A549 human lung cancer cell line.
Results: IONPA were smaller in size with better dispersibility compared with IONPUC. They induced increased reactive oxygen species production, higher DNA damage and apoptosis, which resulted in increased toxicity to cancer cells in comparison to IONPUC.
Conclusion: Higher uptake of IONPA and active components coating the surface, may be responsible for the increased therapeutic efficacy in cancer cells.

Entities:  

Keywords:  amla extract; green synthesis; iron oxide; iron oxide nanoparticle; lung cancer; nanoparticle; nanotherapy; phytochemical screening; reactive oxygen species

Mesh:

Substances:

Year:  2019        PMID: 31414606     DOI: 10.2217/nnm-2019-0111

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  3 in total

Review 1.  Ferrite Nanoparticles-Based Reactive Oxygen Species-Mediated Cancer Therapy.

Authors:  Shancheng Yu; Huan Zhang; Shiya Zhang; Mingli Zhong; Haiming Fan
Journal:  Front Chem       Date:  2021-04-27       Impact factor: 5.221

Review 2.  Recent Advances in Magnetite Nanoparticle Functionalization for Nanomedicine.

Authors:  Roxana Cristina Popescu; Ecaterina Andronescu; Bogdan Stefan Vasile
Journal:  Nanomaterials (Basel)       Date:  2019-12-16       Impact factor: 5.076

Review 3.  Magnetic Nanoparticles in Biology and Medicine: Past, Present, and Future Trends.

Authors:  Deanna D Stueber; Jake Villanova; Itzel Aponte; Zhen Xiao; Vicki L Colvin
Journal:  Pharmaceutics       Date:  2021-06-24       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.